Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Renin inhibitors are one of four classes of compounds that affect the renin-angiotensin-aldosterone system. Renin inhibitors produce vasodilation by inhibiting the activity of renin, which is responsible for stimulating angiotensin II formation. Renin is a proteolytic enzyme that is released by the kidneys in response to sympathetic activation, hypotension, and decreased sodium delivery to the distal renal tubule. Aliskiren (INN) (trade names Tekturna, US; Rasilez, UK and elsewhere) is the first in a class of drugs called direct renin inhibitors. Its current licensed indication is essential (primary) hypertension.
USA is still the largest consumption region of Tekturna, occupied about 56% market share globally, with revenue 39.21 million USD in 2017. At the same time, Asia will see the considerable growth since Novartis DAC had successfully entered into an agreement with Orphan Pacific (Japan) and Lee’s Pharmaceutical Holdings Limited (China).
This report offers an overview of the market trends, drivers, and barriers with respect to the USA Renin-Inhibitors market. It also provides a detailed overview of the market of different regions across West USA, South USA, Middle West USA, Northeast USA. The report deeply analyzes type and application in the USA Renin-Inhibitors market. Detailed analysis of key players, along with key growth strategies adopted by Renin-Inhibitors industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.
By Player:
Noden Pharma
Novartis
By Type:
150mg/Tablet
300mg/Tablet
By End-User:
Age below 45
Age 45-55
Age 55-65
Age above 65
By Region:
-
West USA
-
South USA
-
Middle West USA
-
Northeast USA
TABLE OF CONTENT
1 Report Overview
-
1.1 Product Definition and Scope
-
1.2 PEST (Political, Economic, Social and Technological) Analysis of Renin-Inhibitors Market
-
1.3 Market Segment by Type
-
1.3.1 USA Renin-Inhibitors Market Size and Growth Rate of 150mg/Tablet from 2016 to 2027
-
1.3.2 USA Renin-Inhibitors Market Size and Growth Rate of 300mg/Tablet from 2016 to 2027
-
1.4 Market Segment by Application
-
1.4.1 USA Renin-Inhibitors Market Size and Growth Rate of Age below 45 from 2016 to 2027
-
1.4.2 USA Renin-Inhibitors Market Size and Growth Rate of Age 45-55 from 2016 to 2027
-
1.4.3 USA Renin-Inhibitors Market Size and Growth Rate of Age 55-65 from 2016 to 2027
-
1.4.4 USA Renin-Inhibitors Market Size and Growth Rate of Age above 65 from 2016 to 2027
-
1.5 Market Segment by Regions
-
1.5.1 West USA Renin-Inhibitors Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.2 South USA Renin-Inhibitors Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.3 Middle West USA Renin-Inhibitors Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.4 Northeast USA Renin-Inhibitors Consumption Market Size and Growth Rate from 2016 to 2027
2 Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Market Challenges and Restraints
-
2.1.2 Market Opportunities and Potentials
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape Analysis
-
2.2.1 Industrial Concentration Analysis
-
2.2.2 Porter's Five Forces Analysis of the Industry
-
2.2.3 SWOT Analysis for New Entrants
-
2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry
3 Segmentation of Renin-Inhibitors Market by Types
-
3.1 Products Development Trends of Different Types
-
3.2 Products Types of Major Vendors
-
3.3 Competitive Landscape Analysis of Different Types
-
3.4 Market Size of Renin-Inhibitors by Major Types
-
3.4.1 Market Size and Growth Rate of 150mg/Tablet
-
3.4.2 Market Size and Growth Rate of 300mg/Tablet
4 Segmentation of Renin-Inhibitors Market by End-Users
-
4.1 Downstream Client Analysis by End-Users
-
4.2 Competitive Landscape Analysis of Different End-Users
-
4.3 Market Potential Analysis of Different End-Users
-
4.4 Market Size of Renin-Inhibitors by Major End-Users
-
4.4.1 Market Size and Growth Rate of Renin-Inhibitors in Age below 45
-
4.4.2 Market Size and Growth Rate of Renin-Inhibitors in Age 45-55
-
4.4.3 Market Size and Growth Rate of Renin-Inhibitors in Age 55-65
-
4.4.4 Market Size and Growth Rate of Renin-Inhibitors in Age above 65
5 Market Analysis by Regions
-
5.1 USA Renin-Inhibitors Production Analysis by Regions
-
5.2 USA Renin-Inhibitors Consumption Analysis by Regions
-
5.3 Coronavirus (COVID-19) Impact on USA Economy
6 West USA Renin-Inhibitors Landscape Analysis
-
6.1 West USA Renin-Inhibitors Landscape Analysis by Major Types
-
6.2 West USA Renin-Inhibitors Landscape Analysis by Major End-Users
7 South USA Renin-Inhibitors Landscape Analysis
-
7.1 South USA Renin-Inhibitors Landscape Analysis by Major Types
-
7.2 South USA Renin-Inhibitors Landscape Analysis by Major End-Users
8 Middle West USA Renin-Inhibitors Landscape Analysis
-
8.1 Middle West USA Renin-Inhibitors Landscape Analysis by Major Types
-
8.2 Middle West USA Renin-Inhibitors Landscape Analysis by Major End-Users
9 Northeast USA Renin-Inhibitors Landscape Analysis
-
9.1 Northeast USA Renin-Inhibitors Landscape Analysis by Major Types
-
9.2 Northeast USA Renin-Inhibitors Landscape Analysis by Major End-Users
10 Major Players Profiles
-
10.1 Noden Pharma
-
10.1.1 Noden Pharma Company Profile and Recent Development
-
10.1.2 Market Performance
-
10.1.3 Product and Service Introduction
-
10.2 Novartis
-
10.2.1 Novartis Company Profile and Recent Development
-
10.2.2 Market Performance
-
10.2.3 Product and Service Introduction
The List of Tables and Figures
-
Figure Product Picture
-
Figure USA Renin-Inhibitors Market Size and Growth Rate of 150mg/Tablet from 2016 to 2027
-
Figure USA Renin-Inhibitors Market Size and Growth Rate of 300mg/Tablet from 2016 to 2027
-
Figure Market Share by Type in 2016
-
Figure Market Share by Type in 2020
-
Figure Market Share by Type in 2027
-
Figure USA Renin-Inhibitors Market Size and Growth Rate of Age below 45 from 2016 to 2027
-
Figure USA Renin-Inhibitors Market Size and Growth Rate of Age 45-55 from 2016 to 2027
-
Figure USA Renin-Inhibitors Market Size and Growth Rate of Age 55-65 from 2016 to 2027
-
Figure USA Renin-Inhibitors Market Size and Growth Rate of Age above 65 from 2016 to 2027
-
Figure Market Share by End-User in 2016
-
Figure Market Share by End-User in 2020
-
Figure Market Share by End-User in 2027
-
Figure West USA Renin-Inhibitors Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure South USA Renin-Inhibitors Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Middle West USA Renin-Inhibitors Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northeast USA Renin-Inhibitors Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Development Trends and Industry Dynamics of Renin-Inhibitors Industry
-
Figure Market Challenges and Restraints
-
Figure Market Opportunities and Potentials
-
Table Mergers and Acquisition
-
Figure Market Share of TOP 3 Players in 2019
-
Figure Market Share of TOP 5 Players in 2019
-
Figure Market Share of TOP 6 Players from 2016 to 2020
-
Figure Porter's Five Forces Analysis
-
Figure New Entrant SWOT Analysis
-
Figure Coronavirus (COVID-19) Distribution Map of USA
-
Table Coronavirus (COVID-19) Impact on the Industry
-
Figure Specifications of Different Types of Renin-Inhibitors
-
Figure Development Trends of Different Types
-
Table Products Types of Major Vendors
-
Figure Competitive Landscape Analysis of Different Types
-
Table Consumption of Renin-Inhibitors by Different Types from 2016 to 2027
-
Table Consumption Share of Renin-Inhibitors by Different Types from 2016 to 2027
-
Figure Market Size and Growth Rate of 150mg/Tablet
-
Figure Market Size and Growth Rate of 300mg/Tablet
-
Table Downstream Client Analysis by End-Users
-
Figure Competitive Landscape Analysis of Different End-Users
-
Table Market Potential Analysis of Different End-Users
-
Figure Consumption of Renin-Inhibitors by Different End-Users from 2016 to 2027
-
Table Consumption Share of Renin-Inhibitors by Different End-Users from 2016 to 2027
-
Figure Market Size and Growth Rate of Age below 45
-
Figure Market Size and Growth Rate of Age 45-55
-
Figure Market Size and Growth Rate of Age 55-65
-
Figure Market Size and Growth Rate of Age above 65
-
Table USA Renin-Inhibitors Production by Regions
-
Table USA Renin-Inhibitors Production Share by Regions
-
Figure USA Renin-Inhibitors Production Share by Regions in 2016
-
Figure USA Renin-Inhibitors Production Share by Regions in 2021
-
Figure USA Renin-Inhibitors Production Share by Regions in 2027
-
Table USA Renin-Inhibitors Consumption by Regions
-
Table USA Renin-Inhibitors Consumption Share by Regions
-
Figure USA Renin-Inhibitors Consumption Share by Regions in 2016
-
Figure USA Renin-Inhibitors Consumption Share by Regions in 2021
-
Figure USA Renin-Inhibitors Consumption Share by Regions in 2027
-
Table West USA Renin-Inhibitors Consumption by Types from 2016 to 2027
-
Table West USA Renin-Inhibitors Consumption Share by Types from 2016 to 2027
-
Figure West USA Renin-Inhibitors Consumption Share by Types in 2016
-
Figure West USA Renin-Inhibitors Consumption Share by Types in 2021
-
Figure West USA Renin-Inhibitors Consumption Share by Types in 2027
-
Table West USA Renin-Inhibitors Consumption by End-Users from 2016 to 2027
-
Table West USA Renin-Inhibitors Consumption Share by End-Users from 2016 to 2027
-
Figure West USA Renin-Inhibitors Consumption Share by End-Users in 2016
-
Figure West USA Renin-Inhibitors Consumption Share by End-Users in 2021
-
Figure West USA Renin-Inhibitors Consumption Share by End-Users in 2027
-
Table South USA Renin-Inhibitors Consumption by Types from 2016 to 2027
-
Table South USA Renin-Inhibitors Consumption Share by Types from 2016 to 2027
-
Figure South USA Renin-Inhibitors Consumption Share by Types in 2016
-
Figure South USA Renin-Inhibitors Consumption Share by Types in 2021
-
Figure South USA Renin-Inhibitors Consumption Share by Types in 2027
-
Table South USA Renin-Inhibitors Consumption by End-Users from 2016 to 2027
-
Table South USA Renin-Inhibitors Consumption Share by End-Users from 2016 to 2027
-
Figure South USA Renin-Inhibitors Consumption Share by End-Users in 2016
-
Figure South USA Renin-Inhibitors Consumption Share by End-Users in 2021
-
Figure South USA Renin-Inhibitors Consumption Share by End-Users in 2027
-
Table Middle West USA Renin-Inhibitors Consumption by Types from 2016 to 2027
-
Table Middle West USA Renin-Inhibitors Consumption Share by Types from 2016 to 2027
-
Figure Middle West USA Renin-Inhibitors Consumption Share by Types in 2016
-
Figure Middle West USA Renin-Inhibitors Consumption Share by Types in 2021
-
Figure Middle West USA Renin-Inhibitors Consumption Share by Types in 2027
-
Table Middle West USA Renin-Inhibitors Consumption by End-Users from 2016 to 2027
-
Table Middle West USA Renin-Inhibitors Consumption Share by End-Users from 2016 to 2027
-
Figure Middle West USA Renin-Inhibitors Consumption Share by End-Users in 2016
-
Figure Middle West USA Renin-Inhibitors Consumption Share by End-Users in 2021
-
Figure Middle West USA Renin-Inhibitors Consumption Share by End-Users in 2027
-
Table Northeast USA Renin-Inhibitors Consumption by Types from 2016 to 2027
-
Table Northeast USA Renin-Inhibitors Consumption Share by Types from 2016 to 2027
-
Figure Northeast USA Renin-Inhibitors Consumption Share by Types in 2016
-
Figure Northeast USA Renin-Inhibitors Consumption Share by Types in 2021
-
Figure Northeast USA Renin-Inhibitors Consumption Share by Types in 2027
-
Table Northeast USA Renin-Inhibitors Consumption by End-Users from 2016 to 2027
-
Table Northeast USA Renin-Inhibitors Consumption Share by End-Users from 2016 to 2027
-
Figure Northeast USA Renin-Inhibitors Consumption Share by End-Users in 2016
-
Figure Northeast USA Renin-Inhibitors Consumption Share by End-Users in 2021
-
Figure Northeast USA Renin-Inhibitors Consumption Share by End-Users in 2027
-
Table Company Profile and Development Status of Noden Pharma
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Noden Pharma
-
Figure Sales and Growth Rate Analysis of Noden Pharma
-
Figure Revenue and Market Share Analysis of Noden Pharma
-
Table Product and Service Introduction of Noden Pharma
-
Table Company Profile and Development Status of Novartis
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novartis
-
Figure Sales and Growth Rate Analysis of Novartis
-
Figure Revenue and Market Share Analysis of Novartis
-
Table Product and Service Introduction of Novartis
-
